Short Description

Thrombophilia evaluations are usually performed to assess the need to extend anticoagulation, hence testing should be performed in a steady state, remote from the acute event. Laboratory assays to detect thrombophilic states include highly sensitive and specific test like molecular diagnosis, immunologic and functional assays. Many coagulation factors and inhibitors are affected during acute thrombosis, acute illnesses, inflammatory conditions, pregnancy certain medications. Antithrombin is decreased by heparin and acute thrombosis whereas protein C & S levels are increased during acute thrombosis, but decreased by warfarin. Antiphospholipid antibodies like lupus anticoagulants, anti cardiolipin antibodies & anti beta 2 glycprotein antibodies are also associated with thromboembolic disease states. Higher levels of factor VIII (>150%), factor V leiden mutations and increased homocysteine levels are also associated with increased risk of thromboembolic disease.

PreTest Information

Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory. It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician.

Detail Description

THROMBOPHILIA TOTAL PROFILE Test: Symptoms, Diagnosis, and Cost

Thrombophilia is a medical condition that increases the risk of blood clotting. It can be caused by genetic or acquired factors. Thrombophilia Total Profile Test is a comprehensive test that checks for different factors that increase the risk of blood clotting. In this blog, we will discuss the symptoms, diagnosis, and cost of Thrombophilia Total Profile Test.

Symptoms of Thrombophilia

Thrombophilia may not always cause symptoms. However, some people with thrombophilia may experience the following symptoms:

• Swelling in legs or arms
• Pain and tenderness in legs or arms
• Redness in legs or arms
• Shortness of breath
• Chest pain

If you experience any of these symptoms, it is important to seek medical attention immediately.

Diagnosis of Thrombophilia

Thrombophilia is diagnosed through blood tests. Thrombophilia Total Profile Test is a comprehensive test that checks for different factors that increase the risk of blood clotting. The test includes the following:

• Protein C
• Protein S
• Antithrombin III
• Fibrinogen
• Lupus anticoagulant
• Activated Protein C Resistance (APCR) test
• Factor V Leiden mutation
• Prothrombin gene mutation

If you have a family history of thrombophilia or have experienced blood clots in the past, your doctor may recommend Thrombophilia Total Profile Test.

Cost of Thrombophilia Total Profile Test

The cost of Thrombophilia Total Profile Test in India is around INR 28,000. The cost may vary depending on the location and the lab where the test is performed. However, it is important to note that the test is covered under some health insurance plans. If you have health insurance, it is recommended to check with your insurance provider for coverage details.

Conclusion

Thrombophilia is a medical condition that increases the risk of blood clotting. Thrombophilia Total Profile Test is a comprehensive test that checks for different factors that increase the risk of blood clotting. The test can help in the early diagnosis of thrombophilia and can prevent serious complications. If you have a family history of thrombophilia or have experienced blood clots in the past, it is recommended to talk to your doctor about Thrombophilia Total Profile Test.

At DNA Labs India, we offer Thrombophilia Total Profile Test with accurate results and timely delivery. Contact us today to schedule your test.

Thrombophilia evaluations are usually performed to assess the need to extend anticoagulation, hence testing should be performed in a steady state, remote from the acute event. Laboratory assays to detect thrombophilic states include highly sensitive and specific test like molecular diagnosis, immunologic and functional assays. Many coagulation factors and inhibitors are affected during acute thrombosis, acute illnesses, inflammatory conditions, pregnancy certain medications. Antithrombin is decreased by heparin and acute thrombosis whereas protein C & S levels are increased during acute thrombosis, but decreased by warfarin. Antiphospholipid antibodies like lupus anticoagulants, anti cardiolipin antibodies & anti beta 2 glycprotein antibodies are also associated with thromboembolic disease states. Higher levels of factor VIII (>150%), factor V leiden mutations and increased homocysteine levels are also associated with increased risk of thromboembolic disease.